<ol class="journal" style="margin-right: 0px; margin-bottom: 0px; margin-left: 0px; padding-left: 20px; border-radius: 0px !important;"><li style="margin: 0px; padding-left: 5px; border-radius: 0px !important;">Josefina Doffo, Stefanos A. Bamopoulos, Hazal Köse, Felix Orben, Chuanbing Zang, Miriam Pons, Alexander T. den Dekker, Rutger W. W. Brouwer, Apoorva Baluapuri, Stefan Habringer, Maximillian Reichert, Anuradha Illendula, Oliver H. Krämer, Markus Schick, Elmar Wolf, Wilfred F. J. van IJcken, Irene Esposito, Ulrich Keller, Günter Schneider, Matthias Wirth.&nbsp;<strong style="border-radius: 0px !important;">NOXA expression drives synthetic lethality to RUNX1 inhibition in pancreatic cancer</strong>.&nbsp;<em style="border-radius: 0px !important;">Proceedings of the National Academy of Sciences</em>, 2022; 119 (9): e2105691119 DOI:&nbsp;<a href="http://dx.doi.org/10.1073/pnas.2105691119" rel="nofollow" target="_blank" style="color: rgb(0, 66, 118); border-radius: 0px !important;">10.1073/pnas.2105691119</a></li></ol>